Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT
Clinical trial NCT03389035 · COMPLETED
Trial details
- NCT number
- NCT03389035
- Sponsor
- Fondazione Matilde Tettamanti Menotti De Marchi Onlus
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2021-03-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.